SCHEMBL6404472

SCHEMBL6404472

CC(C)(c1ccccc1)[Si](C)(C)O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.44
ALOX15 P16050 1/20 0.44
ESR1 P03372 3/20 0.43
ESR2 Q92731 3/20 0.43
CYP3A4 P08684 2/20 0.43
MAPK1 P28482 2/20 0.42
MAPT P10636 1/20 0.41
KMT2A Q03164 1/20 0.41
CYP2C19 P33261 1/20 0.40
HIF1A Q16665 1/20 0.40
TAAR1 Q96RJ0 1/20 0.39
HDAC3 O15379 1/20 0.39
HDAC4 P56524 1/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC7 Q8WUI4 1/20 0.39
HDAC2 Q92769 1/20 0.39
HDAC10 Q969S8 1/20 0.39
HDAC11 Q96DB2 1/20 0.39
HDAC8 Q9BY41 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7053156 0.80 ALDH1A1 (0.44) ALDH1A1ALOX15ESR1ESR2CYP3A4
SCHEMBL9210673 0.79 MAPK1 (0.46) ALDH1A1ALOX15ESR1ESR2CYP3A4
SCHEMBL10633204 0.79 TAAR1 (0.48) ALDH1A1ALOX15ESR1ESR2CYP3A4
SCHEMBL6602971 0.77 ALDH1A1 (0.41) ALDH1A1ALOX15ESR1ESR2CYP3A4
SCHEMBL10632875 0.76 MAPK1 (0.44) ALDH1A1ALOX15ESR1ESR2CYP3A4
SCHEMBL6404468 0.75 ESR1 (0.43) ALDH1A1ALOX15ESR1ESR2CYP3A4
SCHEMBL22730177 0.75 MAPK1 (0.42) ALDH1A1ALOX15ESR1ESR2CYP3A4
SCHEMBL22730200 0.75 MAPK1 (0.42) ALDH1A1ALOX15ESR1ESR2CYP3A4
SCHEMBL10633132 0.75 MAPK1 (0.42) ALDH1A1ALOX15ESR1ESR2CYP3A4
Tert-Butylbenzene SCHEMBL28381516 0.74 ALDH1A1 (0.48) ALDH1A1ALOX15ESR1ESR2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6867297-B1 Process for synthesizing 4-substituted azetidinone derivatives DAIICHI SUNTORY PHARMA CO., LTD. (JP) 2005-03-15 US disclosed
US-20050004092-A1 Penem derivatives and antimicrobial agent containing the same DAIICHI SUNTORY PHARMA CO., LTD. (JP) 2005-01-06 US disclosed
EP-0757051-B1 PENEM DERIVATIVES AND ANTIMICROBIAL AGENT CONTAINING THE SAME DAIICHI SUNTORY PHARMA CO LTD (JP) 2003-10-29 EP disclosed
EP-0638552-B1 PROCESS FOR SYNTHESIZING 4-SUBSTITUTED AZETIDINONE DERIVATIVE DAIICHI SUNTORY PHARMA CO LTD (JP) 2003-06-04 EP disclosed
EP-0563878-B1 Process for producing 4-substituted azetidinone derivatives SUNTORY LTD (JP) 2001-08-29 EP disclosed
US-6051569-A 1'S, 5R, 6R-carbapenem derivatives and antimicrobial agents comprising the same SUNTORY LIMITED (JP) 2000-04-18 US disclosed
US-5808055-A Copper catalyzed process for producing 4-substituted azetidinone derivatives SUNTORY LIMITED (JP) 1998-09-15 US disclosed
EP-0826687-A1 Carbapenem derivatives and antimicrobial agents comprising the same SUNTORY LIMITED (JP) 1998-03-04 EP disclosed
EP-0774465-A1 Penem derivatives and antimicrobial agents containing the same SUNTORY LIMITED (JP) 1997-05-21 EP disclosed
EP-0757051-A1 PENEM DERIVATIVES AND ANTIMICROBIAL AGENT CONTAINING THE SAME SUNTORY LIMITED (JP) 1997-02-05 EP disclosed
EP-0372699-B1 Process for the preparation of 4-acyloxy-2-azetidinone derivatives SUNTORY LTD (JP) 1995-02-22 EP disclosed
EP-0638552-A1 PROCESS FOR SYNTHESIZING 4-SUBSTITUTED AZETIDINONE DERIVATIVE SUNTORY LIMITED (JP) 1995-02-15 EP disclosed
EP-0563878-A2 Process for producing 4-substituted azetidinone derivatives SUNTORY LIMITED (JP) 1993-10-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050004092-A1 Penem derivatives and antimicrobial agent containing the same MRPL21, MRPS2, MRPS28 ALDH1A1 1862/4885ALOX15 2988/4885ESR1 3204/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.